Back to Agenda
Keynote Recap - DEI and the Future of Marketing
Session Chair(s)
Fadwa Almanakly, PharmD
Vice President & Head, Advertising and Promotion, Regulatory Affairs Americas
Bayer Pharmaceuticals, United States
Sheetal Patel, PharmD
Vice President, Specialty Compliance
Johnson & Johnson, United States
The keynote recap will host a fireside chat to discuss the FDA’s draft guidance on Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials. We will discuss patients’ perspective on how to reach underrepresented communities and we will raise awareness of the importance of diversity in the drug development lifecycle. We will also have different organizations and stakeholders share their recommendations and success stories in including Diversity, Equity and Inclusion (DEI) in their promotional campaigns.
Learning Objective : At the conclusion of this session, participants should be able to:- Discuss FDA’s expectations based on their draft guidance for Diversity & Inclusion in Clinical Trials
- Recognize the importance of recruiting hard-to-reach populations
- Apply lessons and recommendations to lead a successful inclusive, multicultural marketing campaign
Speaker(s)
Speaker
Kayt Leonard, MA
SAS Institute Inc., United States
Global Health Care and Life Sciences Strategic Advisor
Speaker
Jen Horonjeff, PhD
Savvy Cooperative, United States
Founder and CEO
Have an account?